Download - 1--GMT-PRES ENGLISH-MSTR
![Page 1: 1--GMT-PRES ENGLISH-MSTR](https://reader036.vdocuments.mx/reader036/viewer/2022062316/58ecc8f81a28abfc018b4571/html5/thumbnails/1.jpg)
GlobalMed Technologies Inc.
Medical Technologies for the Future Generation
A Company dedicated to the Treatments and Cure
of Catastrophic Diseases
![Page 2: 1--GMT-PRES ENGLISH-MSTR](https://reader036.vdocuments.mx/reader036/viewer/2022062316/58ecc8f81a28abfc018b4571/html5/thumbnails/2.jpg)
Who is GlobalMed Tech, (GMT)
• GMT is a Bio Medical Technology Company.• GMT has developed a treatment modality which
effectively inactivates the HIV virus.• GMT has Government approval to conduct Controlled
Clinical Trials on 100 subjects in South America.• GMT has patented it’s process and products
worldwide. • GMT Manufactures 5 Main Components:• PCI-1 Hemoirradiator• The GMT - Electronic Master Control Card• GMT Proprietary Software• Patient Intelli - Flash drive Software• The GMT – Cuvette, ( Irradiation Chamber )
![Page 3: 1--GMT-PRES ENGLISH-MSTR](https://reader036.vdocuments.mx/reader036/viewer/2022062316/58ecc8f81a28abfc018b4571/html5/thumbnails/3.jpg)
PCITHE PROCESS OF HEMOIRRADIATION.
• PCI IS THE PROCESS OF EXPOSING A CERTAIN QUANTITY OF BLOOD TO ULTRAVIOLET IRRADIATION VIA A STERILE CLOSED CIRCUIT, CALLED A CUVETTE OR IRRADIATION CHAMBER.
• THE BLOOD NEVER COMES IN CONTACT WITH THE AMBIENT ENVIRONMENT.
![Page 4: 1--GMT-PRES ENGLISH-MSTR](https://reader036.vdocuments.mx/reader036/viewer/2022062316/58ecc8f81a28abfc018b4571/html5/thumbnails/4.jpg)
FUNCTION• AS IN ANY FORM OF THERAPY, THE SUCCESS
OF HEMOIRRADIATION IS DEPENDANT ON THE DOSAGE ADMINISTERED.
• AND• THE CURATIVE PROPERTIES IN VIVO IS
DERIVED FROM THE ACTIVATION AND STIMULATORY EFFECT UPON CELLS AND MOLECULES WHICH COMPOSE HUMAN BLOOD.
![Page 5: 1--GMT-PRES ENGLISH-MSTR](https://reader036.vdocuments.mx/reader036/viewer/2022062316/58ecc8f81a28abfc018b4571/html5/thumbnails/5.jpg)
NIELS FINSEN
• FATHER OF PHOTOTHERAPY:
• Won Nobel Prize in Physiology & Medicine in 1903 “In recognition of his contribution to the treatment of diseases, especially Lupus Vulgaris, with concentrated light radiation, whereby he has opened a new avenue for medical science“
• Dr. Finsen’s contribution to medicine is unparallel. He treated 300 patients with Lupus Vulgaris and demonstrated, 100% success rates. Today, we have nothing in our arsenal of medications that can produce such results.
![Page 6: 1--GMT-PRES ENGLISH-MSTR](https://reader036.vdocuments.mx/reader036/viewer/2022062316/58ecc8f81a28abfc018b4571/html5/thumbnails/6.jpg)
Lester Edblom, medical student and Dr. Emmet Knott scientist, developed the first Hemoirradiator vacuum extraction system and Cuvette. The first Patent was issued in the US for a UV-Irradiator. September 11, 1928.Thousands of people were treated between the 1930’s up to 1969 with a 98% success rate..
![Page 7: 1--GMT-PRES ENGLISH-MSTR](https://reader036.vdocuments.mx/reader036/viewer/2022062316/58ecc8f81a28abfc018b4571/html5/thumbnails/7.jpg)
Emmet Knott Irradiator.
![Page 8: 1--GMT-PRES ENGLISH-MSTR](https://reader036.vdocuments.mx/reader036/viewer/2022062316/58ecc8f81a28abfc018b4571/html5/thumbnails/8.jpg)
![Page 9: 1--GMT-PRES ENGLISH-MSTR](https://reader036.vdocuments.mx/reader036/viewer/2022062316/58ecc8f81a28abfc018b4571/html5/thumbnails/9.jpg)
![Page 10: 1--GMT-PRES ENGLISH-MSTR](https://reader036.vdocuments.mx/reader036/viewer/2022062316/58ecc8f81a28abfc018b4571/html5/thumbnails/10.jpg)
![Page 11: 1--GMT-PRES ENGLISH-MSTR](https://reader036.vdocuments.mx/reader036/viewer/2022062316/58ecc8f81a28abfc018b4571/html5/thumbnails/11.jpg)
EUMATRON
HEMOIRRADIATOR FROM GERMANY.
UTILIZED IN THOUSANDS OF MEDICAL CENTERS
IN EUROPE.
![Page 12: 1--GMT-PRES ENGLISH-MSTR](https://reader036.vdocuments.mx/reader036/viewer/2022062316/58ecc8f81a28abfc018b4571/html5/thumbnails/12.jpg)
PTX4PHOTONIC PUMP
USA.NOT-FDA APPROVEDUTILIZED IN VARIOUS
ALTERNATIVE CENTERS IN THE
US
![Page 13: 1--GMT-PRES ENGLISH-MSTR](https://reader036.vdocuments.mx/reader036/viewer/2022062316/58ecc8f81a28abfc018b4571/html5/thumbnails/13.jpg)
Baxter Fenwal Plasma
Separator. Utilized in the treatment of Scleroderma In San Vicente
Hospital Medellin, Colombia.
![Page 14: 1--GMT-PRES ENGLISH-MSTR](https://reader036.vdocuments.mx/reader036/viewer/2022062316/58ecc8f81a28abfc018b4571/html5/thumbnails/14.jpg)
Treatment of Scleroderma -LupusTime of Tx. 5 hours. Cost: 2,000 to 2,500
US
![Page 15: 1--GMT-PRES ENGLISH-MSTR](https://reader036.vdocuments.mx/reader036/viewer/2022062316/58ecc8f81a28abfc018b4571/html5/thumbnails/15.jpg)
THERAKOSJOHNSON & JOHNSON
Ultraviolet A Irradiator
Irradiator developed by Dr. Elderson and
utilized in clinical trials on AIDS Related ARC patients at Columbia University in 1990. Four subjects were registered as SERO
Negative after 5 to 19 Sessions.
![Page 16: 1--GMT-PRES ENGLISH-MSTR](https://reader036.vdocuments.mx/reader036/viewer/2022062316/58ecc8f81a28abfc018b4571/html5/thumbnails/16.jpg)
Therakos. Time of Tx. 5 hours. Cost: 5,000 US
![Page 17: 1--GMT-PRES ENGLISH-MSTR](https://reader036.vdocuments.mx/reader036/viewer/2022062316/58ecc8f81a28abfc018b4571/html5/thumbnails/17.jpg)
GlobalMed Technologies:
• PCI-1 Hemoirradiator• GMT- Cuvette (Irradiation Chamber)• Electronic Master Control Card• Electronic UV Detector• GMT Proprietary Software• Patient Inteli - Flash drive Software
![Page 18: 1--GMT-PRES ENGLISH-MSTR](https://reader036.vdocuments.mx/reader036/viewer/2022062316/58ecc8f81a28abfc018b4571/html5/thumbnails/18.jpg)
PCI-1 GLOBALMEDTime of Tx. 25 minutes Cost: $75.00 )
![Page 19: 1--GMT-PRES ENGLISH-MSTR](https://reader036.vdocuments.mx/reader036/viewer/2022062316/58ecc8f81a28abfc018b4571/html5/thumbnails/19.jpg)
GMT-PCI-1Bar Code Scanner
UVC Irradiation Bulb
Automatic Peristalsis Pump
Inteliflash-Card
LCD
Keyboard
UV protection Lid
![Page 20: 1--GMT-PRES ENGLISH-MSTR](https://reader036.vdocuments.mx/reader036/viewer/2022062316/58ecc8f81a28abfc018b4571/html5/thumbnails/20.jpg)
GMT-Cuvette
Utilized during Treatments.Developed and Manufactured by
GMT.Patent Registered Worldwide.
![Page 21: 1--GMT-PRES ENGLISH-MSTR](https://reader036.vdocuments.mx/reader036/viewer/2022062316/58ecc8f81a28abfc018b4571/html5/thumbnails/21.jpg)
GMT -Cuvette (Irradiation Chamber)
Prototype
Blood Banks
Human
![Page 22: 1--GMT-PRES ENGLISH-MSTR](https://reader036.vdocuments.mx/reader036/viewer/2022062316/58ecc8f81a28abfc018b4571/html5/thumbnails/22.jpg)
GMT -Cuvette (Irradiation Chamber)
Quartz Glass
External Body
Top
O-Ring 1
O-Ring 2
![Page 23: 1--GMT-PRES ENGLISH-MSTR](https://reader036.vdocuments.mx/reader036/viewer/2022062316/58ecc8f81a28abfc018b4571/html5/thumbnails/23.jpg)
GMT –Kit
![Page 24: 1--GMT-PRES ENGLISH-MSTR](https://reader036.vdocuments.mx/reader036/viewer/2022062316/58ecc8f81a28abfc018b4571/html5/thumbnails/24.jpg)
Hep-Loc IV Catheter Placement.,
Used to extract and re infuse patients blood during
treatment.
Placement of
GMT-Hep-Loc
![Page 25: 1--GMT-PRES ENGLISH-MSTR](https://reader036.vdocuments.mx/reader036/viewer/2022062316/58ecc8f81a28abfc018b4571/html5/thumbnails/25.jpg)
Blood Extraction
Process• Patient sits comfortably and may watch television, read or listen to music during their sessions.
•Up to 300ml of blood is extracted.
• Time of Treatment: Extraction 7-10 min.
Irradiation 5 minRe Infusion 7-10 min
• Total Time : 19-25 min
![Page 26: 1--GMT-PRES ENGLISH-MSTR](https://reader036.vdocuments.mx/reader036/viewer/2022062316/58ecc8f81a28abfc018b4571/html5/thumbnails/26.jpg)
Commencement of Treatment. Blood begins to
enter Cuvette.
![Page 27: 1--GMT-PRES ENGLISH-MSTR](https://reader036.vdocuments.mx/reader036/viewer/2022062316/58ecc8f81a28abfc018b4571/html5/thumbnails/27.jpg)
Irradiation Process.The blood is propelled by the Peristaltic
Pump via the Irradiation Chamber (Cuvette) where the blood is irradiated with the precise amount of UV Dosage. After irradiation the blood continues to
the secondary Blood Bag and from there is returned via a Blood Administration Kit
with a 70um Filter.
![Page 28: 1--GMT-PRES ENGLISH-MSTR](https://reader036.vdocuments.mx/reader036/viewer/2022062316/58ecc8f81a28abfc018b4571/html5/thumbnails/28.jpg)
Re-Infusion Process
![Page 29: 1--GMT-PRES ENGLISH-MSTR](https://reader036.vdocuments.mx/reader036/viewer/2022062316/58ecc8f81a28abfc018b4571/html5/thumbnails/29.jpg)
Government Approved Clinical Study in the
Republic Dominican with 36 Patients living with
HIV/AIDS
![Page 30: 1--GMT-PRES ENGLISH-MSTR](https://reader036.vdocuments.mx/reader036/viewer/2022062316/58ecc8f81a28abfc018b4571/html5/thumbnails/30.jpg)
TREATMENT PROCESS GMT. PROCESS OF BLOOD EXTRACTION.
![Page 31: 1--GMT-PRES ENGLISH-MSTR](https://reader036.vdocuments.mx/reader036/viewer/2022062316/58ecc8f81a28abfc018b4571/html5/thumbnails/31.jpg)
GlobalMed
Process of
IrradiationTime: 25 minutes
Cost $75.00 US/Kit.
![Page 32: 1--GMT-PRES ENGLISH-MSTR](https://reader036.vdocuments.mx/reader036/viewer/2022062316/58ecc8f81a28abfc018b4571/html5/thumbnails/32.jpg)
TREATMENT CENTER
![Page 33: 1--GMT-PRES ENGLISH-MSTR](https://reader036.vdocuments.mx/reader036/viewer/2022062316/58ecc8f81a28abfc018b4571/html5/thumbnails/33.jpg)
Bacterial Membrane Destruction
UV destroys a Bacteria's Membrane there by Inactivating the Bacteria
Before After
![Page 34: 1--GMT-PRES ENGLISH-MSTR](https://reader036.vdocuments.mx/reader036/viewer/2022062316/58ecc8f81a28abfc018b4571/html5/thumbnails/34.jpg)
Virus Destruction
2 Hours 4 Hours 6 Hours
The destruction of a Virus is achieved by Fragmentation which Inactivates the
Virus.
![Page 35: 1--GMT-PRES ENGLISH-MSTR](https://reader036.vdocuments.mx/reader036/viewer/2022062316/58ecc8f81a28abfc018b4571/html5/thumbnails/35.jpg)
Destruction of Fungus
The Destruction of Fungus is achieved by the Photo-Oxidation effect on their
Membranes which prohibits Biosynthesis.
Before 24 Hours 48 Hours
![Page 36: 1--GMT-PRES ENGLISH-MSTR](https://reader036.vdocuments.mx/reader036/viewer/2022062316/58ecc8f81a28abfc018b4571/html5/thumbnails/36.jpg)
PROTOCOL ISUV-001-04
CLASSIFICATION BY AGE AGE GROUP SUBJECTS
18 – 30 1231 – 40 1641 – 51 8 TOTAL: 36
![Page 37: 1--GMT-PRES ENGLISH-MSTR](https://reader036.vdocuments.mx/reader036/viewer/2022062316/58ecc8f81a28abfc018b4571/html5/thumbnails/37.jpg)
PROTOCOLO ISUV-001-04 STUDY DECREASE PROGRESSION
VIRAL LOAD VIRAL LOAD• ROCHE 116A (8 WEEKS) 52% 48%• ROCHE 116A (16 WEEKS) 46% 54%• ROCHE 116B/117 (8 WEEKS) 55% 45%• ROCHE 116B/117 (16 WEEKS) 55% 45%
• GMT-PCI 2004-001 (4 WEEKS) 58% 42%• GMT-PCI 2004-001 (8 WEEKS) 76% 24%• GMT-PCI 2004-001 (12 WEEKS) 84% 16%
GMT PCI REGIMENT COMPARED TO A DOUBLE BRANCH STUDY PERFORMED BY
ROCHE , UTILIZING RETROVIRAL REGIMENT OF ZDV, AND ddl.
![Page 38: 1--GMT-PRES ENGLISH-MSTR](https://reader036.vdocuments.mx/reader036/viewer/2022062316/58ecc8f81a28abfc018b4571/html5/thumbnails/38.jpg)
BEFORE AND AFTER PHOTOS.AFTER 90 DAYS OF TREATMENT, 100% OF OPPORTUNISTIC INFECTIONS HAD
SUBSIDED.GMT believes it can reduce the cost to keep one HIV/AIDS patient alive by 90% a year.
Savings to Medicare and Medicaid would be in the Billions.
Current Across the Board yearly cost in US to keep 1 million HIV/AIDS patients alive = 20 Billion
Estimated cost with GMT Protocol 1 million patients
1.5 to 2 Billion
![Page 39: 1--GMT-PRES ENGLISH-MSTR](https://reader036.vdocuments.mx/reader036/viewer/2022062316/58ecc8f81a28abfc018b4571/html5/thumbnails/39.jpg)
PRE TREATMENTPRE TREATMENT AFTER 2 AFTER 2 TREATMENTS.TREATMENTS.
WEEK 2WEEK 2
AFTER 4 AFTER 4 TREATMENTS.TREATMENTS.
WEEK 4WEEK 4
![Page 40: 1--GMT-PRES ENGLISH-MSTR](https://reader036.vdocuments.mx/reader036/viewer/2022062316/58ecc8f81a28abfc018b4571/html5/thumbnails/40.jpg)
AFTER 2 TREATMENTS (WEEK 2)AFTER 2 TREATMENTS (WEEK 2)PRE TREATMENTPRE TREATMENT
![Page 41: 1--GMT-PRES ENGLISH-MSTR](https://reader036.vdocuments.mx/reader036/viewer/2022062316/58ecc8f81a28abfc018b4571/html5/thumbnails/41.jpg)
PRE TREATMENTPRE TREATMENT AFTER 2 TREATMENTS AFTER 2 TREATMENTS (WEEK 2) (WEEK 2)
![Page 42: 1--GMT-PRES ENGLISH-MSTR](https://reader036.vdocuments.mx/reader036/viewer/2022062316/58ecc8f81a28abfc018b4571/html5/thumbnails/42.jpg)
PRE TREATMENTPRE TREATMENT AFTER 2 TREATMENTS AFTER 2 TREATMENTS (WEEK 2) (WEEK 2)
![Page 43: 1--GMT-PRES ENGLISH-MSTR](https://reader036.vdocuments.mx/reader036/viewer/2022062316/58ecc8f81a28abfc018b4571/html5/thumbnails/43.jpg)
AFTER 2 TREATMENTS AFTER 2 TREATMENTS (WEEK 2) (WEEK 2)PRE TREATMENTPRE TREATMENT
![Page 44: 1--GMT-PRES ENGLISH-MSTR](https://reader036.vdocuments.mx/reader036/viewer/2022062316/58ecc8f81a28abfc018b4571/html5/thumbnails/44.jpg)
PRE TREATMENTPRE TREATMENT AFTER 2 TREATMENTS AFTER 2 TREATMENTS (WEEK 2) (WEEK 2)
![Page 45: 1--GMT-PRES ENGLISH-MSTR](https://reader036.vdocuments.mx/reader036/viewer/2022062316/58ecc8f81a28abfc018b4571/html5/thumbnails/45.jpg)
PRE TREATMENTPRE TREATMENT AFTER 2 TREATMENTS AFTER 2 TREATMENTS (WEEK 2) (WEEK 2)
![Page 46: 1--GMT-PRES ENGLISH-MSTR](https://reader036.vdocuments.mx/reader036/viewer/2022062316/58ecc8f81a28abfc018b4571/html5/thumbnails/46.jpg)
AFTER 2 TREATMENTS AFTER 2 TREATMENTS (WEEK 2)(WEEK 2)PRE TREATMENTPRE TREATMENT
![Page 47: 1--GMT-PRES ENGLISH-MSTR](https://reader036.vdocuments.mx/reader036/viewer/2022062316/58ecc8f81a28abfc018b4571/html5/thumbnails/47.jpg)